Author:
Bailie George R.,Larkina Maria,Goodkin David A.,Li Yun,Pisoni Ronald L.,Bieber Brian,Mason Nancy,Tong Lin,Locatelli Francesco,Marshall Mark R.,Inaba Masaaki,Robinson Bruce M.
Reference50 articles.
1. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD;Van Buren;Int Urol Nephrol,2012
2. DOPPS Practice Monitor: Emerging Trends,2012
3. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases;US Renal Data System,2010
4. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin;Hasegawa;Kidney Int,2011
5. International trends in erythropoietin use and hemoglobin levels in hemodialysis patients;McFarlane;Kidney Int,2010